These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 17509532)
1. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening. Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives. Freundlich JS; Anderson JW; Sarantakis D; Shieh HM; Yu M; Valderramos JC; Lucumi E; Kuo M; Jacobs WR; Fidock DA; Schiehser GA; Jacobus DP; Sacchettini JC Bioorg Med Chem Lett; 2005 Dec; 15(23):5247-52. PubMed ID: 16198563 [TBL] [Abstract][Full Text] [Related]
3. Design and in silico screening of combinatorial library of antimalarial analogs of triclosan inhibiting Plasmodium falciparum enoyl-acyl carrier protein reductase. Frecer V; Megnassan E; Miertus S Eur J Med Chem; 2009 Jul; 44(7):3009-19. PubMed ID: 19217192 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 2: 2'-substituted triclosan derivatives. Freundlich JS; Yu M; Lucumi E; Kuo M; Tsai HC; Valderramos JC; Karagyozov L; Jacobs WR; Schiehser GA; Fidock DA; Jacobus DP; Sacchettini JC Bioorg Med Chem Lett; 2006 Apr; 16(8):2163-9. PubMed ID: 16466916 [TBL] [Abstract][Full Text] [Related]
5. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives. Kumar SP; George LB; Jasrai YT; Pandya HA SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142 [TBL] [Abstract][Full Text] [Related]
6. Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. Kumar G; Parasuraman P; Sharma SK; Banerjee T; Karmodiya K; Surolia N; Surolia A J Med Chem; 2007 May; 50(11):2665-75. PubMed ID: 17477517 [TBL] [Abstract][Full Text] [Related]
7. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum. Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275 [TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR studies on triclosan derivatives as Plasmodium falciparum enoyl acyl carrier reductase inhibitors. Shah P; Siddiqi MI SAR QSAR Environ Res; 2010 Jul; 21(5-6):527-45. PubMed ID: 20818586 [TBL] [Abstract][Full Text] [Related]
9. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083 [TBL] [Abstract][Full Text] [Related]
10. Design, development, synthesis, and docking analysis of 2'-substituted triclosan analogs as inhibitors for Plasmodium falciparum enoyl-ACP reductase. Kapoor N; Banerjee T; Babu P; Maity K; Surolia N; Surolia A IUBMB Life; 2009 Nov; 61(11):1083-91. PubMed ID: 19859979 [TBL] [Abstract][Full Text] [Related]
11. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents. Muench SP; Prigge ST; McLeod R; Rafferty JB; Kirisits MJ; Roberts CW; Mui EJ; Rice DW Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):328-38. PubMed ID: 17327670 [TBL] [Abstract][Full Text] [Related]
12. Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). Sharma SK; Parasuraman P; Kumar G; Surolia N; Surolia A J Med Chem; 2007 Feb; 50(4):765-75. PubMed ID: 17263522 [TBL] [Abstract][Full Text] [Related]
14. X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition. Maity K; Bhargav SP; Sankaran B; Surolia N; Surolia A; Suguna K IUBMB Life; 2010 Jun; 62(6):467-76. PubMed ID: 20503440 [TBL] [Abstract][Full Text] [Related]
16. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches. Neves BJ; Bueno RV; Braga RC; Andrade CH Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236 [TBL] [Abstract][Full Text] [Related]
17. SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase. Kumar G; Banerjee T; Kapoor N; Surolia N; Surolia A IUBMB Life; 2010 Mar; 62(3):204-13. PubMed ID: 20131353 [TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum. Banerjee T; Sharma SK; Surolia N; Surolia A Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222 [TBL] [Abstract][Full Text] [Related]
19. Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum. Suguna K; Surolia A; Surolia N Biochem Biophys Res Commun; 2001 Apr; 283(1):224-8. PubMed ID: 11322792 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological and crystallographic evaluation of novel inhibitors of Plasmodium falciparum enoyl-ACP-reductase (PfFabI). Belluti F; Perozzo R; Lauciello L; Colizzi F; Kostrewa D; Bisi A; Gobbi S; Rampa A; Bolognesi ML; Recanatini M; Brun R; Scapozza L; Cavalli A J Med Chem; 2013 Oct; 56(19):7516-26. PubMed ID: 24063369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]